| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| O97231 (RL44_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Large ribosomal subunit protein eL42; 60S ribosomal protein L44; | |
| Q7KQL8 (THIO1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Thioredoxin 1; | |
| O96184 (RL37A_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Large ribosomal subunit protein eL43; 60S ribosomal protein L37a; | |
| A0A144A2H0 (AMPP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Aminopeptidase P; Xaa-Pro aminopeptidase; | |
| Q8I5Z5 (YPF09_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1205000; | |
| Q8I5G1 (YPF10_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1225600; | |
| C0H537 (TRM5_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | tRNA (guanine(37)-N(1))-methyltransferase; M1G-methyltransferase; tRNA [GM37] methyltransferase; tRNA methyltransferase 5 homolog; | |
| Q8I5R7 (SYP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Proline--tRNA ligase; Prolyl-tRNA synthetase; | |
| Q8ID66 (PF92_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Merozoite surface protein P92; | |
| Q8IDR3 (MYOA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Myosin-A; PfMyoA; | |
| Q8I6U8 (GBP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glycophorin-binding protein 130; | |
| Q8IEK7 (ISD11_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein Isd11; | |
| Q8I719 (KGP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | cGMP-dependent protein kinase; PfPKG; | |
| Q8I299 (E140_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative iron transporter; | |
| Q8IKD3 (PDED_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | cGMP-specific 3',5'-cyclic phosphodiesterase delta; | |
| Q8IJX8 (ALBA3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Endonuclease ALBA3; DNA/RNA-binding protein Alba 3; | |
| Q8I0V0 (SUB1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Subtilisin-like protease 1; PfSUB1; | |
| Q7K734 (FEN1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Flap endonuclease 1; Flap structure-specific endonuclease 1; | |
| Q8ID39 (Y13P2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein MAL13P1.336; | |
| Q8I3M7 (DMT1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Divalent metal transporter 1; Food vacuole resident transporter 1; PfNRAMP; | |
| Q8I1U7 (SMC3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Structural maintenance of chromosomes protein 3 homolog; | |
| O96269 (RS30_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Small ribosomal subunit protein eS30; 40S ribosomal protein S30; | |
| Q8IC32 (Y7014_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Leucine-rich repeat and coiled-coil domain-containing protein PF3D7_0703800; | |
| Q8I6Z7 (PDEB_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase beta; | |
| O97237 (YGCC1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | GRIP and coiled-coil domain-containing protein; | |
| O96935 (AMPN_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Aminopeptidase N; M1 alanyl aminopeptidase; M1 family aminopeptidase; PfA-M1; p120 form; p96 form; p68 form; p35 form; | |
| Q8IJK4 (MNMA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative tRNA-specific 2-thiouridylase; | |
| O97302 (RH5IP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Rh5-interacting protein; | |
| Q8I335 (GUF1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Translation factor GUF1 homolog, mitochondrial; Elongation factor 4 homolog; GTPase GUF1 homolog; Ribosomal back-translocase; | |
| Q76NL8 (FCLN_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Falcilysin; | |
| Q8I397 (MFRN_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative mitoferrin; Mitochondrial carrier protein MRS3; | |
| Q8I615 (ORC1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Origin recognition complex subunit 1; | |
| Q8IIG7 (YPF05_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1120000; | |
| Q6LFN2 (TEXP1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Trophozoite exported protein 1; | |
| O77374 (PF07_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PFC0810c; | |
| Q25802 (RPOC2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | DNA-directed RNA polymerase subunit beta''; PEP; Plastid-encoded RNA polymerase subunit beta''; | |
| Q8ILP3 (P113_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Surface protein P113; | |
| Q8I5V4 (PDEA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | cGMP-specific 3',5'-cyclic phosphodiesterase alpha; | |
| Q8IDH9 (ATM1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | ABC transporter ATM1; ABC transporter B family member 6, putative; PfMDR6; | |
| Q8IM00 (YPF03_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1409500; | |
| Q8IM46 (YPF02_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1404800; | |
| Q8IC19 (YPF13_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF07_0021; | |
| Q8IKU0 (GLUPH_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Bifunctional glucose-6-phosphate 1-dehydrogenase/6-phosphogluconolactonase; 6-phosphogluconolactonase; 6PGL; 3.1.1.31; Glucose-6-phosphate 1-dehydrogenase; G6PD; 1.1.1.49; | |
| Q8IBB8 (YPF15_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein MAL8P1.12; | |
| P21421 (RPOB_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | DNA-directed RNA polymerase subunit beta; PEP; Plastid-encoded RNA polymerase subunit beta; | |
| Q9TY96 (SERA6_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Serine-repeat antigen protein 6; Cysteine protease SERA6; | |
| Q8I2A6 (CBPZ1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative zinc carboxypeptidase; | |
| Q8I5I1 (YL135_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1223600; | |
| Q8IL26 (EIK1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Eukaryotic translation initiation factor 2-alpha kinase 1; | |
| Q8IKW2 (SIR2B_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | NAD-dependent protein deacetylase Sir2B; Regulatory protein SIR2 homolog B; SIR2-like protein B; |
Plasmodium falciparum is a protozoan parasite that resides in human red blood cells, but can also infect the brain and liver. P. falciparum is one of the species of Plasmodium that causes malaria in humans. It has a complex life-cycle requiring both human and female Anopheles mosquito. P. falciparum is responsible for the disease's most dangerous form, malignant or falciparum malaria, which has the highest complication rates and mortality.
With more than 200 million cases and 400,000 deaths from malaria worldwide, P. falciparum (causing roughly 50% of the cases) has been the focus of malaria research for decades.
The genome of P. falciparum was first sequenced in 2002.
From left to right: i) The number of proteins in the reference proteome of Plasmodium falciparum, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Plasmodium falciparum for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Plasmodium falciparum, please visit UniProtKB.
You can easily download the latest protein sequences for Plasmodium falciparum proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_04 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 5,361 | 3,842 | 6,732 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Plasmodium falciparum reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Plasmodium falciparum proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 10-mer | 12-mer | 14-mer | 16-mer | 24-mer | 32-mer | 40-mer | 60-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6,060 | 468 | 33 | 68 | 9 | 49 | 9 | 5 | 4 | 10 | 3 | 3 | 3 | 2 | 3 | 3 |
